Poul Videbech
Poul Videbech is an expert in Psychiatry at Copenhagen University Hospital (Denmark). As of October 2026, ScienceLeadR ranks Poul Videbech in the top 1% of experts worldwide for Psychological Techniques. Poul Videbech has authored 221 publications, the most recent in 2026, and is an investigator in 17 clinical trials, 4 of them ongoing. SLR score: 804 (community average: 125). How the SLR is computed.
LeadR Profile
Psychiatry
Subspecialties: Neurology - Public Health - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2001 - 2026
Number : 221
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Anterograde and retrograde amnesia following electroconvulsive therapy: A controlled longitudinal study accounting for time and depression. PMID 42872397 — depression, amnesia, retrograde, longitudinal studies, amnesia, anterograde, cognitive reserve, accounting, therapeutics, amnesia, memory, electroconvulsive therapy | Psychol Med | 2026 | 0 |
| Depressive and anxiety symptoms during CGRP-targeted migraine prevention: A systematic review and meta-analysis. PMID 42731077 — headache, depression, genes, migraine disorders, signs and symptoms, therapeutics | Cephalalgia | 2026 | 1 |
| Postpartum Psychotropic Treatment Patterns and Breastfeeding: Nationwide Clustering Study. PMID 42669595 — polypharmacy, epidemiology, mothers, drug utilization, cohort studies, prescriptions, breast feeding, drug-related side effects and adverse reactions, breast, psychotropic drugs, prevalence, cluster analysis, pharmacology, clinical, epidemiologic methods, antipsychotic agents, therapeutics, product surveillance, postmarketing, pharmacoepidemiology, postpartum period | Pharmacoepidemiol Drug Saf | 2026 | 0 |
| Symptom Burden and Quality of Life in Patients With Severe Mental Disorders Initiating Cancer Treatment. PMID 42570504 — quality of life, mental disorders, neoplasms, therapeutics | Clin Oncol (R Coll Radiol) | 2026 | 1 |
| Methodological limitations of anxiety screening tools used in migraine studies -a narrative review. PMID 42307416 — headache, migraine disorders, diagnosis, generalized anxiety disorder | Cephalalgia | 2026 | 0 |
Clinical Studies 17
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| COpenhagen Magnetic Personalized Accelerated Brain Circuit Therapy for Treatment Resistant Depression NCT06895863 — depression, brain, transcranial magnetic stimulation, depressive disorder, prefrontal cortex, work, therapeutics, depressive disorder, treatment-resistant, pulse, depressive disorder, major | N/A | Recruiting | 2025 |
| A Randomized Clinical Trial Comparing Active Versus Sham T PEMF Headband Treatment for Depression NCT06005103 — depression, sleep, placebos, duration of therapy, signs and symptoms, depressive disorder, therapeutics, cognition, psychiatry | N/A | Recruiting | 2024 |
| Schema Therapy for Patients With Chronic Treatment Resistant Depression NCT05833087 — depression, personality disorders, personality, psychotherapy, prescriptions, depressive disorder, therapeutics, depressive disorder, treatment-resistant, wounds and injuries, schema therapy, cognition, psychiatry, psychiatrists | N/A | Recruiting | 2023 |
| Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9) NCT05913947 — depression, antidepressive agents, bipolar disorder, tablets, therapeutics, universities | Phase 4 | Recruiting | 2022 |
LeadR Networks
Main global connection map